- Release Date: 24/06/19 09:55
- Summary: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs
- Price Sensitive: Yes
- Download Document 134.93KB
Ann: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.5¢ |
Change
-0.010(1.29%) |
Mkt cap ! $887.7M | |||
| Open | High | Low | Value | Volume |
| 76.5¢ | 80.3¢ | 76.0¢ | $5.022M | 6.472M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 425429 | 76.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.5¢ | 3903 | 1 |
View Market Depth
| Last trade - 16.10pm 19/04/2024 (20 minute delay) ? |
|
|||||
|
Last
76.5¢ |
Change
-0.010 ( 1.20 %) |
||||
| Open | High | Low | Volume | ||
| 78.0¢ | 80.0¢ | 76.0¢ | 2064486 | ||
| Last updated 15.59pm 19/04/2024 ? | |||||
| MSB (ASX) Chart |